National Health Investors Inc NHI
Institutional shares held
30.6 Million
11.5K
calls
14.6K
puts
Total value of holdings
$2.32B
$871K
calls
$1.11M
puts
Market Cap
$3.38B
44,655,200
Shares Out.
Institutional ownership
68.59%
# of Institutions
300
We take great care to ensure that the data presented and summarized in this overview for NATIONAL HEALTH INVESTORS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding NHI
View all-
Vanguard Group Inc Valley Forge, PA6.42MShares$487 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.41MShares$334 Million0.01% of portfolio
-
State Street Corp Boston, MA1.89MShares$143 Million0.01% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.65MShares$125 Million0.07% of portfolio
-
Macquarie Group LTD Australia, C31.11MShares$84.4 Million0.09% of portfolio
-
Geode Capital Management, LLC Boston, MA1.11MShares$84.4 Million0.01% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA877KShares$66.4 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX634KShares$48.1 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC619KShares$46.9 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL614KShares$46.5 Million0.01% of portfolio
Latest Institutional Activity in NHI
Top Purchases
Top Sells
About NHI
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Insider Transactions at NHI
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
Mar 28
2025
|
Robert G Adams Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
32,935
-8.78%
|
$2,437,190
$74.7 P/Share
|
|
Mar 28
2025
|
Robert G Adams Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
45,000
+3.95%
|
$2,475,000
$55.3 P/Share
|
|
Mar 03
2025
|
D. Eric Mendelsohn CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+7.65%
|
-
|
|
Mar 03
2025
|
Kristin Sallee Gaines SVP/Chief Transaction Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+6.07%
|
-
|
|
Mar 03
2025
|
Kevin Carlton Pascoe Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,500
+8.23%
|
-
|
|
Mar 03
2025
|
John L Spaid CFO/EVP Finance |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+12.7%
|
-
|
|
Mar 03
2025
|
David L Travis SVP/Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,500
+20.33%
|
-
|
|
Feb 23
2025
|
John L Spaid CFO/EVP Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
267
-0.69%
|
$18,156
$68.96 P/Share
|
|
Feb 23
2025
|
D. Eric Mendelsohn CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
267
-0.3%
|
$18,156
$68.96 P/Share
|
|
Sep 27
2024
|
W Andrew Adams Director |
SELL
Other acquisition or disposition
|
Indirect |
12,635
-100.0%
|
-
|
|
Sep 25
2024
|
Kristin Sallee Gaines SVP/Chief Transaction Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
48,665
-45.65%
|
$4,087,860
$84.66 P/Share
|
|
Sep 25
2024
|
Kristin Sallee Gaines SVP/Chief Transaction Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
55,000
+17.55%
|
$3,795,000
$69.2 P/Share
|
|
Sep 18
2024
|
David L Travis SVP/Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,406
-39.33%
|
$884,510
$85.15 P/Share
|
|
Sep 18
2024
|
David L Travis SVP/Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+16.05%
|
$828,000
$69.2 P/Share
|
|
Sep 05
2024
|
D. Eric Mendelsohn CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
130,461
-59.5%
|
$10,697,802
$82.1 P/Share
|
|
Sep 05
2024
|
D. Eric Mendelsohn CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
164,999
+16.91%
|
$8,909,946
$54.57 P/Share
|
|
Sep 03
2024
|
Robert T Webb Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
52,353
-46.74%
|
$4,188,240
$80.04 P/Share
|
|
Sep 03
2024
|
Robert T Webb Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
70,000
+16.42%
|
$4,060,000
$58.77 P/Share
|
|
Sep 03
2024
|
John L Spaid CFO/EVP Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
49,637
-56.35%
|
$4,020,597
$81.43 P/Share
|
|
Sep 03
2024
|
John L Spaid CFO/EVP Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
62,167
+13.51%
|
$3,357,018
$54.57 P/Share
|
Last 12 Months Summary
Buy / Acquisition
795K
Shares
From
16
Insiders
| Exercise of conversion of derivative security | 765K shares |
|---|---|
| Grant, award, or other acquisition | 29.5K shares |
| Open market or private purchase | 437 shares |
Sell / Disposition
627K
Shares
From
11
Insiders
| Payment of exercise price or tax liability | 614K shares |
|---|---|
| Other acquisition or disposition | 12.6K shares |